233. Wolfram syndrome Clinical trials / Disease details


Clinical trials : 9 Drugs : 15 - (DrugBank : 7) / Drug target genes : 11 - Drug target pathways : 41

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2020-004594-43-FR
(EUCTR)
11/03/2021AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutationAUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation - AUDIOWOLF Wolfram syndrome
MedDRA version: 20.0;Level: PT;Classification code 10078338;Term: Wolfram syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Trade Name: DEPAKINE CHRONO® 500 mg
Product Name: DEPAKINE CHRONO 500 mg
CECS/I-StemNULLNAFemale: yes
Male: yes
23Phase 2France